-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EPI-589 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EPI-589 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EPI-589 in Parkinson's Disease Drug Details: EPI-589 (PTC-589) is under development for...
-
Product Insights
NewNet Present Value Model: Sumitomo Pharma Co Ltd’s EPI-589
Empower your strategies with our Net Present Value Model: Sumitomo Pharma Co Ltd's EPI-589 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EPI-004 in Cancer Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EPI-004 in Cancer Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EPI-004 in Cancer PainDrug Details:EPI-004 is under development for the treatment of chronic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EPI-006 in Opium (Opioid) Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EPI-006 in Opium (Opioid) Addiction report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Riboflavin + Sodium Iodide) in Keratoconus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Riboflavin + Sodium Iodide) in Keratoconus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Riboflavin + Sodium Iodide) in Keratoconus Drug Details: A fixed-combination...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VMD-928 in Colon Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VMD-928 in Colon Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VMD-928 in Colon Cancer Drug Details: VMD-928 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-718 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-718 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-718 in Refractory Acute Myeloid Leukemia Drug Details: KITE-718...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Triplex in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Triplex in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Triplex in Mantle Cell Lymphoma Drug Details: Triplex is under...